These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 15025337)

  • 21. Recent Canadian experience with targeted hepatitis C virus lookback.
    Goldman M; Patterson L; Long A
    Transfusion; 2006 May; 46(5):690-4. PubMed ID: 16686835
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [HCV genotypes in Polish blood donors in period 1995-2007].
    Brojer E; Grabarczyk P; Kopacz A; Potepa A; Medyńska J; Smolarczyk-Wodzyńska J; Letowska M
    Przegl Epidemiol; 2008; 62(1):163-9. PubMed ID: 18536240
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hepatitis C virus infection among Thai blood donors: antibody prevalence, risk factors and development of risk screening form.
    Luksamijarulkul P; Thammata N; Sujirarat D; Tiloklurs M
    Southeast Asian J Trop Med Public Health; 2004 Mar; 35(1):147-54. PubMed ID: 15272759
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The hepatitis C virus genotype and subtype frequency in hepatitis C virus RNA-positive, hepatitis C virus antibody-negative blood donors identified in the nucleic acid test screening program in Poland.
    Brojer E; Gronowska A; Medyńska J; Grabarczyk P; Mikulska M; Letowska M; Kryczka W; Gietka A
    Transfusion; 2004 Dec; 44(12):1706-10. PubMed ID: 15584984
    [TBL] [Abstract][Full Text] [Related]  

  • 25. First fully automated blood screening test for HCV antibodies approved.
    AIDS Patient Care STDS; 2007 Aug; 21(8):608. PubMed ID: 17902247
    [No Abstract]   [Full Text] [Related]  

  • 26. Microbiological screening of blood donations: cost versus effectiveness.
    Barbara JA
    Med Lab Sci; 1989 Jul; 46(3):250-4. PubMed ID: 2514335
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Should cost benefit analysis be done when new routines are introduced?].
    Bäck E
    Lakartidningen; 1991 Feb; 88(9):720-2. PubMed ID: 1900555
    [No Abstract]   [Full Text] [Related]  

  • 28. [Serological and molecular markers of HCV infection in Polish blood donors].
    Brojer E
    Przegl Epidemiol; 2005; 59(2):511-7. PubMed ID: 16190561
    [TBL] [Abstract][Full Text] [Related]  

  • 29. High prevalence of hepatitis B, C and delta virus infections among blood donors in Mongolia.
    Tsatsralt-Od B; Takahashi M; Nishizawa T; Inoue J; Ulaankhuu D; Okamoto H
    Arch Virol; 2005 Dec; 150(12):2513-28. PubMed ID: 16012782
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Determination of alanine aminotransferase in blood donor screening--evidence of its usefulness in the prevention of post-transfusion hepatitis.
    Khouri ST; Lopes EP; Perez RM; Figueiredo VM; Lanzoni VP; Silva AE; Ferraz ML
    Clin Lab; 2004; 50(5-6):291-4. PubMed ID: 15209437
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Seroprevalence of hepatitis B and C virus infections among Lao blood donors.
    Jutavijittum P; Yousukh A; Samountry B; Samountry K; Ounavong A; Thammavong T; Keokhamphue J; Toriyama K
    Southeast Asian J Trop Med Public Health; 2007 Jul; 38(4):674-9. PubMed ID: 17883005
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Seroprevalence of hepatitis C virus among blood donors in Rivers State, Nigeria.
    Koate BB; Buseri FI; Jeremiah ZA
    Transfus Med; 2005 Oct; 15(5):449-51. PubMed ID: 16202063
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Prevalence of antibody to hepatitis C virus in blood donors. Analysis of confirmed results].
    Wolff C; Jirón MI; Elgueta R; Vera M; Toriello L; Martínez L; Parraguez A
    Rev Med Chil; 1996 May; 124(5):615-6. PubMed ID: 9035517
    [No Abstract]   [Full Text] [Related]  

  • 34. Significance of the signal-to-cutoff ratios of anti-hepatitis C virus enzyme immunoassays in screening of Chinese blood donors.
    Ren FR; Lv QS; Zhuang H; Li JJ; Gong XY; Gao GJ; Liu CL; Wang JX; Yao FZ; Zheng YR; Zhu FM; Tiemuer MH; Bai XH; Shan H
    Transfusion; 2005 Nov; 45(11):1816-22. PubMed ID: 16271110
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Trends in hepatitis B and hepatitis C seroprevalence among Nepalese blood donors.
    Karki S; Ghimire P; Tiwari BR; Maharjan A; Rajkarnikar M
    Jpn J Infect Dis; 2008 Jul; 61(4):324-6. PubMed ID: 18653982
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Anti-hepatitis C virus-positive blood donors: are women any different?
    Narciso-Schiavon JL; Schiavon LL; Carvalho-Filho RJ; Freire FC; Cardoso JR; Bordin JO; Silva AE; Ferraz ML
    Transfus Med; 2008 Jun; 18(3):175-83. PubMed ID: 18598280
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [ALT determination in blood donors].
    Franco E; Sedeño M
    Sangre (Barc); 1994 Apr; 39(2):153. PubMed ID: 8059298
    [No Abstract]   [Full Text] [Related]  

  • 38. Predonation screening of blood donors with rapid tests: implementation and efficacy of a novel approach to blood safety in resource-poor settings.
    Owusu-Ofori S; Temple J; Sarkodie F; Anokwa M; Candotti D; Allain JP
    Transfusion; 2005 Feb; 45(2):133-40. PubMed ID: 15660820
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Impact of pooling on accuracy of hepatitis B virus surface antigen screening of blood donations.
    Novack L; Sarov B; Goldman-Levi R; Yahalom V; Safi J; Soliman H; Orgel M; Yaari A; Galai N; Pliskin JS; Shinar E
    Trans R Soc Trop Med Hyg; 2008 Aug; 102(8):787-92. PubMed ID: 18486172
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The cost-effectiveness of predonation screening for transfusion transmissible infections using rapid test kits in a hospital-based blood transfusion centre.
    Dosunmu AO; Akinbami AA; Ismail AK; Olaiya MA; Uche EI; Aile IK
    Niger Postgrad Med J; 2017; 24(3):162-167. PubMed ID: 29082905
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.